The FDA: Faster, but not necessarily better. And that could threaten the agency's brand
Faster FDA drug approvals may reflect less rigorous evidentiary standards, a new analysis suggests.
In 1962, the regulatory scrutiny of medicines by the FDA intensified …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
